U.S. markets closed
  • S&P 500

    4,127.99
    -0.81 (-0.02%)
     
  • Dow 30

    33,745.40
    -55.20 (-0.16%)
     
  • Nasdaq

    13,850.00
    -50.19 (-0.36%)
     
  • Russell 2000

    2,233.78
    -9.69 (-0.43%)
     
  • Crude Oil

    59.81
    +0.11 (+0.18%)
     
  • Gold

    1,733.20
    +0.50 (+0.03%)
     
  • Silver

    24.85
    -0.01 (-0.05%)
     
  • EUR/USD

    1.1918
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    1.6750
    +0.0090 (+0.54%)
     
  • GBP/USD

    1.3755
    +0.0012 (+0.09%)
     
  • USD/JPY

    109.3590
    -0.0170 (-0.02%)
     
  • BTC-USD

    59,967.34
    -222.75 (-0.37%)
     
  • CMC Crypto 200

    1,288.55
    -6.03 (-0.47%)
     
  • FTSE 100

    6,889.12
    -26.63 (-0.39%)
     
  • Nikkei 225

    29,538.73
    -229.33 (-0.77%)
     

New Strong Sell Stocks for January 21st

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

GFL Environmental Inc. GFL operates as a diversified environmental services company. The Zacks Consensus Estimate for its current year earnings has been revised 50% downward over the last 30 days.

LivePerson, Inc. LPSN provides conversational commerce solutions. The Zacks Consensus Estimate for its current year earnings has been revised 16.7% downward over the last 30 days.

TAL Education Group TAL provides K-12 after-school tutoring services. The Zacks Consensus Estimate for its current year earnings has been revised 15.3% downward over the last 30 days.

89bio, Inc. ETNB is a clinical-stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 0.5% downward over the last 30 days.

Ontrak, Inc. OTRK operates as an artificial intelligence powered, virtualized outpatient healthcare treatment company. The Zacks Consensus Estimate for its current year earnings has been revised 66.7% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
TAL Education Group (TAL) : Free Stock Analysis Report
 
LivePerson, Inc. (LPSN) : Free Stock Analysis Report
 
GFL Environmental Inc. (GFL) : Free Stock Analysis Report
 
89BIO INC (ETNB) : Free Stock Analysis Report
 
Catasys Inc. (OTRK) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.